role of rebates in glp-1 pbm decisions 📢 CMS Announces Medicare Bridge Demonstration Program The Centers for Medicare & Medicaid Services (CMS) has released new guidance on the Medicare GLP-1 Bridge, a short-term demonstration program running July 1 –December PBM Power Map: How Pharmacy

FDA has issued a warning letter to Zoll Medical Corporation following a 14-month inspection that uncovered significant manufacturing violations affecting critical medical devices including automated external defibrillators, MRI-compatible ventilators, and electrodes

This helps offset the list price but does not always translate into lower costs for patients, especially those in high-deductible plans

Patients considering GLP-1 medications often start by discussing weight loss goals, medical history, and previous diet or exercise efforts with a clinician

Neither medication is a magic pill

Longitudinal analyses from the Phase 2 and Phase 3 trials show that the incidence of new-onset nausea and vomiting peaked during the first 4-8 weeks of treatment and then declined substantially during the maintenance phase